All In Biotech

Free tool

FAERS Monitor: Finacea

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207071 or its brand name (Finacea, Azelaic Acid). Reports on generic versions are filed under their own applications.

Reports

848

Serious

450

53% of reports

Hospitalization

167

Death reported

84

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective154
  • pain131
  • off label use118
  • abdominal pain upper112
  • vomiting110
  • product use in unapproved indication103
  • gastrooesophageal reflux disease102
  • paraesthesia102
  • migraine101
  • memory impairment99
  • hypoaesthesia98
  • rash97
  • blepharospasm95
  • taste disorder93
  • drug intolerance91

Reports by year received

View as table
YearReports
20042
20051
20061
20085
20093
20108
20112
20122
20133
20146
201520
201617
201714
201827
201930
202059
202168
202271
202386
2024134
2025139
2026150

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,311 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blepharospasmSignal95379.8313.734,989
taste disorderSignal93114.294.210,287
gastrooesophageal reflux diseaseSignal10231.526.22,986
migraineSignal10126.321.92,438
drug intoleranceSignal9123.419.31,935
memory impairmentSignal9917.914.91,570
hypoaesthesiaSignal9816.213.51,396
paraesthesiaSignal10216.113.41,438
abdominal pain upperSignal11213.511.41,296
product use in unapproved indicationSignal10310.38.6867
vomitingSignal1105.84.9442
rashSignal975.54.6362
painSignal1315.34.5465
off label useSignal1183.32.8200
drug ineffectiveSignal1542.92.5202

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.